Subcutaneous Implantable Defibrillator System Market Overview
A subcutaneous implantable defibrillator system is a type of defibrillator which continuously monitors the heart rates in cardiac patients. Being placed subcutaneously, it generates electric impulses to treat heart suffering from ventricular tachyarrhythmia and normalized the heart rhythm. Subcutaneous implantable defibrillator system (S-ICD) helps to save patient life by regulating irregular heartbeat. It is generally not used in patient with symptomatic bradycardia. Subcutaneous implantable defibrillator system (S-ICD) consists of titanium case powered with battery and circuit that offers defibrillation therapy, subcutaneous electrodes and accessories.
Subcutaneous implantable defibrillator systems is programmed in order to deliver tier therapy like antitachycardia pacing (ATP) and cardioversion shocks for treating slower hemodynamically stable ventricular tachycardia’s and high energy shocks for treating hemodynamically unstable VT and ventricular fibrillation (VF). Fast ventricular tachycardia are common in cardiac patients. Antitachycardia pacing helps to reduce these episodes by decreasing incidences for syncope. Antitachycardia pacing against fast ventricular tachycardia’s helps to decrease morbidity for shocks.
Get Free Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2128
Subcutaneous implantable defibrillator system Market: Dynamics
The major factors driving the global subcutaneous implantable defibrillator systems market are rising incidences of cardiovascular diseases, increasing awareness about cardiovascular disorders, rising need for cardiac monitoring system like subcutaneous implantable defibrillator systems, etc. According to report published by WHO in 2015, 17.5 million people died due to cardiovascular disease which represents 31% of the global death. Factors contributing to increasing prevalence of cardiovascular diseases are growing aging population, changing lifestyle, increasing disposable income, smoking, etc.
Subcutaneous implantable defibrillator systems market has anticipated to grow at significant growth rate in next few years owing to increase in the cardiac patient pool. The American Heart Association has recommended several guidelines to use subcutaneous implantable defibrillator systems in order to produce desirable impact on arrhythmia. The conditions like acute myocardial infarction, myocardial ischemia, electrolyte imbalance and drug toxicity leads to arrhythmia, which could be life threatening when not treated efficiently. Monitoring patients with arrhythmia with subcutaneous implantable defibrillator system has proven to deliver effective treatment. With significant scope, subcutaneous implantable defibrillator systems market has anticipated to imbibe a high potential with a significant growth rate.
Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-2128
Subcutaneous implantable defibrillator system Market: Region-wise Outlook
The market in North America is expected to grow rapidly due to high demand for new and innovative products. According to a recent report by the Japan Aging Research Center, the Asia – Pacific is on the verge of suffering from aging of population. Japan, China, and South Korea are the countries experiencing highest problem of aging population followed to rising risk for cardiovascular diseases.
Subcutaneous implantable defibrillator system Market: Key Players
The Key players operating in the global subcutaneous implantable defibrillator systems market are Boston Scientific Corporation, Imricor Medical Systems, Inc., LivaNova PLC Company, Mayo Clinic US, Medtronic plc, MicroPort Scientific Corporation, MRI Interventions, Inc., St. Jude Medical, Inc., etc.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/2128
Subcutaneous implantable defibrillator system Market: Segmentation
By Product Type
- Single Zone
- Dual Zone
- Others
By End User
- Hospitals
- Clinics
- Ambulatory surgical centers
- Cardiac catheterization laboratory
- Others
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs